AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

VENTURE LIFE GROUP PLC

Remuneration Information Jan 6, 2020

8004_dirs_2020-01-06_ee949ece-bf9b-4985-9eb4-4fb77b1ea997.html

Remuneration Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8950Y

Venture Life Group PLC

06 January 2020

6 January 2020

Venture Life Group plc

("Venture Life" or the "Company")

Grant of Options

Venture Life (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the self-care market, announces that it has granted further share options ("Options") over ordinary shares of 0.3 pence each in the capital of the Company ("Ordinary Shares"). 

On 6 January 2020 (the "Date of Grant"), Venture Life granted Options over a total of 4,000,000 Ordinary Shares to its four Executive Directors at a strike price of 33.7 pence per share, being the average of the closing market price on the five business days starting 19 December 2019.  Vesting of the Options is subject to continued employment. The Options will vest in equal tranches on the following dates: 31 March 2020, 31 March 2021 and 31 March 2022.

Director Position Number of Options in this grant
Jerry Randall Chief Executive Officer 1,000,000
Gianluca Braguti Chief Manufacturing Officer 1,000,000
Sharon Collins Chief Commercial Officer 1,000,000
Andrew Waters Chief Financial Officer 1,000,000

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail. 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.)

Names

1.     Jerry Randall

2.     Gianluca Braguti

3.     Sharon Collins

4.     Andrew Waters

2.

Reason for the notification

a.)

Position/status

1.     Chief Executive Officer

2.     Chief Manufacturing Officer

3.     Chief Commercial Officer

4.     Chief Financial Officer

b.)

Initial notification /Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.)

Name

Venture Life Group PLC

b.)

LEI

213800S8CZUPLAB2KC70

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.)

Description of the financial instrument, type of instrument

Options over Ordinary Shares of 0.3 pence each in Venture Life Group plc

b.)

Identification code

GB00BFPM8908

c.)

Nature of the transaction

Grant of Options over Ordinary Shares

d.)

Price and volumes

Price Volume
1.     33.7 pence

2.     33.7 pence

3.     33.7 pence

4.     33.7 pence
1.     1,000,000

2.     1,000,000

3.     1,000,000

4.     1,000,000

e.)

Aggregated information

- Aggregated volume

- Price

n/a

f.)

Date of the transaction

6 January 2020

g.)

Place of the transaction

Outside a trading venue

For further information please contact: 

Venture Life Group PLC +44 (0) 1344 578 004
Jerry Randall, Chief Executive Officer
Andrew Waters, Chief Financial Officer
Cenkos (Nominated Adviser and Joint Broker) +44 (0) 207 397 8900
Mark Connelly / Stephen Keys / Cameron MacRitchie (Corporate Finance) / Russell Kerr / Michael Johnson (Sales)
Alma PR [email protected] or +44 (0) 203 405 0208
Helena Bogle/Hilary Buchanan/Jessica Joynson

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHFLFVELRIRIII

Talk to a Data Expert

Have a question? We'll get back to you promptly.